(Q35871999)

10 August 2017

1 reference

title

Testing for HER2 in breast cancer (English)

1 reference

10 August 2017

Lewis F

1

1 reference

10 August 2017

Jackson P

2

1 reference

10 August 2017

Lane S

3

1 reference

10 August 2017

Coast G

4

1 reference

10 August 2017

Hanby AM

5

1 reference

10 August 2017

publication date

1 September 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

45

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

207-217

1 reference

Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Pathogenesis of Paget's disease: epidermal heregulin-alpha, motility factor, and the HER receptor family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Emerging technologies for HER2 testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

21 January 2018

Formaldehyde fixation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

The foundations of successful RT in situ PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

PCR Amplification from Paraffin-Embedded Tissues: Effects of Fixative and Fixation Time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Gold-facilitated in situ hybridization: a bright-field autometallographic alternative to fluorescence in situ hybridization for detection of Her-2/neu gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Subtracted, unique-sequence, in situ hybridization: experimental and diagnostic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

HER-2/neu gene copy number quantified by real-time PCR: comparison of gene amplification, heterozygosity, and immunohistochemical status in breast cancer tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Evaluation of HER2/neu status by real-time quantitative PCR in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Comparison of two quantitative polymerase chain reaction methods for detecting HER2/neu amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

The clinical evaluation of HER-2 status: which test to use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

Improved procedure for fluorescence in situ hybridization on tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2004.01903.X

10.1111/J.1365-2559.2004.01903.X

21 January 2018

Identifiers

DOI

1 reference

release_rmkitzn76vhzxfv463tlohnxjy

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rmkitzn76vhzxfv463tlohnxjy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference